Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 1, 2003, Pages 86-91

  Mayorga, Cristobalina ^a   Torres, Maria José ^a   Corzo, José Luis ^a   Sanchez Sabate, Elena ^b   Alvarez, Javier ^b   Vera, Angel ^a   Posadas, Sinforiano ^b   Jurado, Antonio ^a   Blanca, Miguel ^a,b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; DEXAMETHASONE; DNA; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; LAMOTRIGINE; PERFORIN; RNA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BLISTER; BLOOD; CASE REPORT; CEREBRAL PALSY; DRUG MEGADOSE; EPILEPSY; FEVER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MALE; MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PUNCH BIOPSY; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TOXIC EPIDERMAL NECROLYSIS;

EID: 0041843806     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62065-0     Document Type: Article

References (20)

1. Roujeau JC, Stern RS. Severe cutaneous adverse reactions to drugs. N Engl J Med. 1994;331:1272-1285.
2. Becker DS. Toxic epidermal necrolysis. Lancet. 1998;351:1417-1420.
3. Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol. 1987;123:1166-1170.
4. Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y. T-cell subsets in drug-induced toxic epidermal necrolysis: possible pathogenic mechanism induced by CD8-positive T cells. Arch Dermatol. 1991;127:851-855.
5. Paquet P, Jacob E, Damas P, Pierad GE. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins. Burns. 2001;27:652-655.
6. Leyva L, Torres MJ, Posadas S, et al. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response. J Allergy Clin Immunol. 2000;105:157-165.
7. Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show levels of perforin, granzyme B and Fas-L to be related to disease severity. J Allergy Clin Immunol. 2002;109:155-161.
8. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998;282:490-493.
9. Wolkenstein P, Latarjet J, Roujeau JC, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet. 1998;352:1586-1589.
10. Magina S, Lisboa C, Gonçalves E, Conceicao F, Leal V, Mesquita-Guimaraes J. A case of toxic epidermal necrolysis treated with intravenous immunoglobulin. Br J Dermatol. 2000;142:191-192.
11. Stella M, Cassano P, Bollero D, Clemente A, Giorio G. Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience. Dermatology. 2001;203:45-49.
12. Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: the University of Miami experience. Arch Dermatol. 2003;139:39-43.
13. Prins C, Kerdel FA, Padilla RS, et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol. 2003;139:26-32.
14. Tristani-Firouzi P, Petersen MJ, Saffle JR, Morris SE, Zone JJ. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol. 2002;47:548-552.
15. Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol. 2003;139:33-36.
16. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
17. Siebert PD, Lanick J. Competitive PCR. Nature. 1992;359:557-558.
18. Le Cleach L, Delaire S, Boumsell L, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-230.
19. Criton S, Devi K, Sridevi PK, Asokan PU. Toxic epidermal necrolysis: a retrospective study. Int J Dermatol. 1997;36:923-925.
20. Posadas SJ, Leyva L, Torres MJ, et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol. 2000;106:769-776.